Lexaria BioscienceLEXX
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 28 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, up 7 from Q4 2025. 7 opened new positions and 2 sold out. The largest holders were Invenomic Capital Management LP ($345K), Geode Capital Management, LLC ($229K) and Vanguard Capital Management LLC ($173K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $70K |
| Exits | 2 | $250 |
All 13F filers, Q4 2025 → Q1 2026: 165,674 shares bought and 444,122 shares sold, net −278,448 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Invenomic Capital Management LP | 0.02% | Reduce -6.1% | 442,301 | $345K |
| Geode Capital Management, LLC | 0.00% | Add +33.9% | 294,157 | $229K |
| Vanguard Capital Management LLC | 0.00% | — | 222,293 | $173K |
| Toronto Dominion Bank | 0.00% | No change | 140,013 | $109K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 94,166 | $73K |
| UBS Group AG | 0.00% | Reduce -85.4% | 52,708 | $41K |
| State Street Corp. | 0.00% | No change | 39,301 | $31K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $21K |
| XTX Topco Ltd | 0.00% | New | 25,067 | $20K |
| Krilogy Financial LLC | 0.00% | No change | 19,653 | $19K |
| Vontobel Holding Ltd. | 0.00% | New | 23,000 | $18K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $14K |
| HRT Financial LP | 0.00% | New | 18,465 | $14K |
| Renaissance Technologies | 0.00% | Add +4.5% | 16,300 | $13K |
| Bank of Montreal | 0.00% | Reduce -0.4% | 14,033 | $11K |
| Citadel Advisors | 0.00% | New | 13,513 | $11K |
| Vanguard Global Advisers, LLC | 0.00% | — | 10,204 | $8K |
| BCV Asset Management Inc. | 0.00% | New | 10,000 | $8K |
| Royal Bank of Canada | 0.00% | Reduce -2.0% | 7,140 | $6K |
| Byrne Asset Management LLC | 0.00% | Reduce -99.2% | 800 | $624 |
| Osaic Holdings, Inc. | 0.00% | Reduce -72.4% | 605 | $471 |
| Citigroup Inc. | 0.00% | New | 489 | $381 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 382 | $298 |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $144 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $10 |
| Morgan Stanley | 0.00% | No change | 3 | $2 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -93.8% | 2 | $2 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.